Evidence map›Paper›PMID 35406569›Full record

ArticleCancers2022

Formulation and Characterization of Poly (Ethylene Glycol)-Coated Core-Shell Methionine Magnetic Nanoparticles as a Carrier for Naproxen Delivery: Growth Inhibition of Cancer Cells.

Faten Eshrati Yeganeh, Amir Eshrati Yeganeh, Mohammad Yousefi, Bahareh Farasati Far, Iman Akbarzadeh, Dmitry Olegovich Bokov, Kaamran Raahemifar, Madjid Soltani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 4 countries.

Faten Eshrati YeganehDepartment of Chemistry, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
Amir Eshrati YeganehDepartment of Microbiology, Noor Dahesh Institute of Higher Education, 45789427600 Meymeh, Iran.
Mohammad YousefiDepartment of Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, 899854961 Tehran, Iran.
Bahareh Farasati FarDepartment of Chemistry, Iran University of Science and Technology, 1684613114 Tehran, Iran.
Iman AkbarzadehDepartment of Chemical and Petrochemical Engineering, Sharif University of Technology, 1458889694 Tehran, Iran.
Dmitry Olegovich BokovInstitute of Pharmacy, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0003-2968-2466
Kaamran RaahemifarFaculty of Science, School of Optometry and Vision Science, University of Waterloo, Waterloo, ON N2L 3G1, Canada.ORCID 0000-0002-9835-7897
Madjid SoltaniFaculty of Science, School of Optometry and Vision Science, University of Waterloo, Waterloo, ON N2L 3G1, Canada.ORCID 0000-0003-0878-6274
Iran University of Science and Technology · IRIslamic Azad University, Science and Research Branch · IRIslamic Azad University, Tehran · IRPennsylvania State University · USSadra Institute Of Higher Education · IRSechenov University · RUSharif University of Technology · IRUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An efficient and selective drug delivery vehicle for cancer cells can remarkably improve therapeutic approaches. In this study, we focused on the synthesis and characterization of magnetic Ni

Indexed as

cell linedrug deliverymethionineMTT assayNi1−xCoxFe2O4 NPsPEGylating

Identifiers

PMID35406569
PMCPMC8997395
OpenAlexW4223571323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.